Scinovex
article Open AccessTop 1% cited

Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

Cell Reports · 2014 · Vol. 7(1) · pp. 1–11
Brian J. WaingerEvangelos KiskinisCassidy MellinOle WiskowSteve S.W. HanJackson SandoeNuma P. PerezLuis A. WilliamsSeungkyu LeeGabriella L. BoultingJames D. BerryRobert H. BrownMerit CudkowiczBruce P. BeanKevin EgganClifford J. Woolf

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor nervous system. We show using multielectrode array and patch-clamp recordings that hyperexcitability detected by clinical neurophysiological studies of ALS patients is recapitulated in induced pluripotent stem cell-derived motor neurons from ALS patients harboring superoxide dismutase 1 (SOD1), C9orf72, and fused-in-sarcoma mutations. Motor neurons produced from a genetically corrected but otherwise isogenic SOD1(+/+) stem cell line do not display the hyperexcitability phenotype. SOD1(A4V/+) ALS patient-derived motor neurons have reduced delayed-rectifier potassium current amplitudes relative to control-derived motor neurons, a deficit that may underlie their hyperexcitability. The Kv7 channel activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS cases. Therefore, electrophysiological characterization of human stem cell-derived neurons can reveal disease-related mechanisms and identify therapeutic candidates.

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchNerve injury and regenerationAmyotrophic lateral sclerosisNeuroscienceMotor neuronMultiple sclerosisMedicineChemistryBiologyPathologyDiseaseSpinal cord

MeSH terms

Superoxide Dismutase-1Action PotentialsAmyotrophic Lateral SclerosisCell DifferentiationCells, CulturedGene Expression RegulationHumansMotor NeuronsMutationPhenotypeSuperoxide DismutasePatch-Clamp TechniquesInduced Pluripotent Stem Cells

Funding

  • National Institutes of Health
Citations
677
FWCI
45.13
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
Induced pluripotent stem cell technology: a decade of progress
Nature Reviews Drug Discovery · 2016 · 1,499 citations
References
Neural<i>KCNQ</i>(Kv7) channels
British Journal of Pharmacology · 2009 · 653 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.